Search





Search





Markets
/
Stocks
/
kros
/

Keros Therapeutics Inc

KROS

Add to Watchlist

10.070USD

-0.150-1.47%

Close 07-31 16:00（ET）Quotes delayed by 15 min

199.30MMarket Cap

LossP/E TTM

Keros Therapeutics Inc

10.070

-0.150-1.47%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

KROS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Keros Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-102.19%-3.53M

40.68%-27.29M

110.65%3.25M

25.57%-29.62M

461.69%161.17M

-80.71%-46.01M

10.25%-30.50M

-29.09%-39.80M

-30.16%-44.56M

-18.73%-25.46M

-38.13%-33.98M

-36.49%-30.83M

-2299.09%-34.23M

-9.60%-21.44M

-70.36%-24.60M

-28.08%-22.59M

86.42%-1.43M

-144.84%-19.57M

-33.02%-14.44M

-77.67%-17.64M

-29.37%-10.51M

-45.34%-7.99M

-267.38%-10.86M

-97.28%-9.93M

-223.12%-8.12M

---5.50M

---2.96M

---5.03M

---2.51M

Net income from continuing operations

-115.97%-23.71M

49.03%-23.46M

86.25%-7.28M

32.17%-30.70M

444.32%148.45M

-14.37%-46.03M

-34.27%-52.96M

-20.67%-45.26M

-20.42%-43.11M

-35.42%-40.24M

-67.77%-39.44M

-37.55%-37.51M

-48.04%-35.80M

-328.21%-29.72M

-15.82%-23.51M

-74.54%-27.27M

-52.26%-24.19M

34.99%-6.94M

-68.64%-20.30M

-45.23%-15.62M

-33.58%-15.88M

-288.08%-10.68M

-239.14%-12.04M

-277.04%-10.76M

-273.61%-11.89M

---2.75M

---3.55M

---2.85M

---3.18M

Operating gains losses

17.15%403.00K

20.48%400.00K

25.80%395.00K

20.92%370.00K

24.19%344.00K

34.41%332.00K

49.52%314.00K

60.21%306.00K

65.87%277.00K

94.49%247.00K

66.67%210.00K

-37.99%191.00K

47.79%167.00K

22.12%127.00K

22.33%126.00K

238.46%308.00K

41.25%113.00K

38.67%104.00K

43.06%103.00K

33.82%91.00K

26.98%80.00K

27.12%75.00K

30.91%72.00K

38.78%68.00K

40.00%63.00K

--59.00K

--55.00K

--49.00K

--45.00K

Other non-cash items

8.90%636.00K

8.74%622.00K

8.17%609.00K

71.97%595.00K

72.27%584.00K

70.75%572.00K

65.10%563.00K

-2.26%346.00K

-35.06%339.00K

4.36%335.00K

61.61%341.00K

71.84%354.00K

157.14%522.00K

-64.61%321.00K

135.82%211.00K

100.00%206.00K

105.05%203.00K

825.51%907.00K

-1302.04%-589.00K

13.19%103.00K

11.24%99.00K

-87.56%98.00K

107.60%49.00K

139.47%91.00K

81.63%89.00K

--788.00K

---645.00K

--38.00K

--49.00K

Change in working capital

341.82%12.94M

-20.55%-12.16M

-56.60%5.54M

-111.50%-8.42M

128.91%2.93M

-246.64%-10.09M

435.49%12.76M

-336.04%-3.98M

-110.60%-10.13M

123.31%6.88M

38.60%-3.80M

-44.46%-913.00K

-126.65%-4.81M

118.16%3.08M

-290.15%-6.20M

87.55%-632.00K

566.97%18.05M

-1812.83%-16.96M

992.60%3.26M

-985.04%-5.08M

27.81%2.71M

126.82%990.00K

-436.76%-365.00K

84.01%-468.00K

5530.77%2.12M

---3.69M

---68.00K

---2.93M

---39.00K

-Change in receivables

121.77%3.17M

1.23%-2.33M

3309.38%12.32M

564.41%1.48M

-17428.92%-14.55M

-1546.15%-2.35M

---384.00K

--222.00K

---83.00K

---143.00K

--0.00

----

100.00%0.00

-100.00%0.00

100.00%0.00

--18.00M

---18.00M

--100.00K

-112.42%-100.00K

-100.00%0.00

100.00%0.00

-100.00%0.00

316.98%805.00K

164.29%117.00K

---34.00K

--35.00K

---371.00K

---182.00K

-Change in prepaid expenses

244.97%15.67M

102.69%141.00K

-24.50%4.43M

19.89%-5.10M

201.45%4.54M

-1073.28%-5.25M

237.86%5.87M

-327.54%-6.37M

-9.92%-4.48M

299.63%539.00K

-1584.32%-4.26M

63.70%-1.49M

-633.25%-4.07M

-120.35%-270.00K

155.09%287.00K

-19.77%-4.10M

-28.66%764.00K

75.53%1.33M

-142.57%-521.00K

-30.08%-3.42M

231.25%1.07M

2338.71%756.00K

17385.71%1.22M

-2007.97%-2.63M

-147.58%-816.00K

--31.00K

--7.00K

--138.00K

--1.71M

-Change in other current assets

-100.00%0.00

100.00%0.00

-100.00%0.00

1880.77%463.00K

--1.59M

1.88%-469.00K

--491.00K

---26.00K

----

---478.00K

----

--0.00

---1.57M

----

--0.00

-100.00%0.00

100.00%0.00

--760.00K

---156.00K

---282.00K

---18.00K

--0.00

-Change in other current liabilities

-100.00%0.00

---155.00K

---770.00K

---2.38M

--3.31M

----

100.00%0.00

-6.67%-16.00K

-14.29%-16.00K

-15.38%-15.00K

0.00%-15.00K

99.40%-15.00K

99.44%-14.00K

99.48%-13.00K

99.40%-15.00K

---2.52M

---2.51M

Cash from non-recurring investing activities

Cash from operating activities

-102.19%-3.53M

40.68%-27.29M

110.65%3.25M

25.57%-29.62M

461.69%161.17M

-80.71%-46.01M

10.25%-30.50M

-29.09%-39.80M

-30.16%-44.56M

-18.73%-25.46M

-38.13%-33.98M

-36.49%-30.83M

-2299.09%-34.23M

-9.60%-21.44M

-70.36%-24.60M

-28.08%-22.59M

86.42%-1.43M

-144.84%-19.57M

-33.02%-14.44M

-77.67%-17.64M

-29.37%-10.51M

-45.34%-7.99M

-267.38%-10.86M

-97.28%-9.93M

-223.12%-8.12M

---5.50M

---2.96M

---5.03M

---2.51M

Investing cash flow

Net cash from continuing investing activities

-87.08%73.00K

-53.63%134.00K

-65.80%132.00K

132.26%720.00K

-40.27%565.00K

-46.58%289.00K

-29.82%386.00K

-0.32%310.00K

-10.92%946.00K

54.13%541.00K

212.50%550.00K

-45.15%311.00K

622.45%1.06M

120.75%351.00K

21.38%176.00K

11.18%567.00K

-30.00%147.00K

165.00%159.00K

383.33%145.00K

1721.43%510.00K

19.32%210.00K

233.33%60.00K

-63.41%30.00K

-83.63%28.00K

--176.00K

--18.00K

--82.00K

--171.00K

--0.00

Capital expenditures

-87.08%73.00K

-53.63%134.00K

-65.80%132.00K

132.26%720.00K

-40.27%565.00K

-46.58%289.00K

-29.82%386.00K

-0.32%310.00K

-10.92%946.00K

54.13%541.00K

212.50%550.00K

-45.15%311.00K

622.45%1.06M

120.75%351.00K

21.38%176.00K

11.18%567.00K

-30.00%147.00K

165.00%159.00K

383.33%145.00K

1721.43%510.00K

19.32%210.00K

233.33%60.00K

-63.41%30.00K

-83.63%28.00K

--176.00K

--18.00K

--82.00K

--171.00K

--0.00

Net cash flow from disposal of fixed assets

-87.08%73.00K

-53.63%134.00K

-65.80%132.00K

132.26%720.00K

-40.27%565.00K

-46.58%289.00K

-29.82%386.00K

-0.32%310.00K

-10.92%946.00K

54.13%541.00K

212.50%550.00K

-45.15%311.00K

622.45%1.06M

120.75%351.00K

21.38%176.00K

11.18%567.00K

-30.00%147.00K

165.00%159.00K

383.33%145.00K

1721.43%510.00K

19.32%210.00K

233.33%60.00K

-63.41%30.00K

-83.63%28.00K

--176.00K

--18.00K

--82.00K

--171.00K

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

87.08%-73.00K

53.63%-134.00K

65.80%-132.00K

-132.26%-720.00K

40.27%-565.00K

46.58%-289.00K

29.82%-386.00K

0.32%-310.00K

10.92%-946.00K

-54.13%-541.00K

-212.50%-550.00K

45.15%-311.00K

-622.45%-1.06M

-120.75%-351.00K

-21.38%-176.00K

-11.18%-567.00K

30.00%-147.00K

-165.00%-159.00K

-383.33%-145.00K

-1721.43%-510.00K

-19.32%-210.00K

-233.33%-60.00K

63.41%-30.00K

83.63%-28.00K

---176.00K

---18.00K

---82.00K

---171.00K

--0.00

Financing cash flow

Cash flow from continuous financing activities

-58000.00%-2.32M

-601.21%-378.63M

-99.91%140.00K

-99.52%17.00K

-100.00%4.00K

9.08%75.54M

54809.86%155.94M

102.93%3.53M

45.62%156.80M

12.76%69.25M

-99.42%284.00K

-82.93%1.74M

91152.54%107.68M

116.13%61.42M

138708.57%48.58M

17780.70%10.19M

180.95%118.00K

-79.72%28.42M

288.89%35.00K

-99.94%57.00K

-99.92%42.00K

3502825.00%140.12M

50.00%9.00K

2503000.00%100.12M

--55.79M

--4.00K

--6.00K

--4.00K

--0.00

Net cash flow from common stock issuance/repurchase

----

-613.00%-375.00M

----

6.69%73.10M

--155.07M

--629.00K

41.03%151.34M

11.59%68.52M

-100.00%0.00

--107.31M

117.96%61.40M

--48.49M

--9.69M

----

-79.95%28.17M

--0.00

-100.00%0.00

----

--140.53M

--0.00

--102.67M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

--56.00M

----

--0.00

Proceeds from stock option exercised by employees

75.00%7.00K

-94.81%127.00K

-86.11%140.00K

-99.43%17.00K

-99.93%4.00K

204.10%2.44M

224.12%1.01M

70.52%2.97M

1446.22%5.72M

688.24%804.00K

223.96%311.00K

246.61%1.74M

213.56%370.00K

-58.37%102.00K

174.29%96.00K

780.70%502.00K

180.95%118.00K

3400.00%245.00K

288.89%35.00K

533.33%57.00K

223.08%42.00K

75.00%7.00K

50.00%9.00K

125.00%9.00K

--13.00K

--4.00K

--6.00K

--4.00K

--0.00

Net cash flow from other financing activities

---2.32M

---3.76M

100.00%0.00

-381.48%-130.00K

---65.00K

---259.00K

22.99%-67.00K

---27.00K

----

---87.00K

----

100.00%0.00

--0.00

100.00%0.00

---420.00K

--0.00

---2.56M

---219.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-58000.00%-2.32M

-601.21%-378.63M

-99.91%140.00K

-99.52%17.00K

-100.00%4.00K

9.08%75.54M

54809.86%155.94M

102.93%3.53M

45.62%156.80M

12.76%69.25M

-99.42%284.00K

-82.93%1.74M

91152.54%107.68M

116.13%61.42M

138708.57%48.58M

17780.70%10.19M

180.95%118.00K

-79.72%28.42M

288.89%35.00K

-99.94%57.00K

-99.92%42.00K

3502825.00%140.12M

50.00%9.00K

2503000.00%100.12M

--55.79M

--4.00K

--6.00K

--4.00K

--0.00

Net cash flow

Beginning cash balance

-48.54%288.86M

30.59%694.92M

69.91%691.66M

62.74%721.99M

68.91%561.38M

84.06%532.13M

25.89%407.07M

25.77%443.65M

18.54%332.36M

20.08%289.11M

49.05%323.35M

53.43%352.76M

21.18%280.38M

8.12%240.75M

-8.55%216.95M

-9.95%229.91M

-13.02%231.37M

66.27%222.68M

63.83%237.23M

367.33%255.32M

3627.97%265.99M

958.95%133.93M

823.60%144.80M

161.69%54.63M

-69.50%7.13M

--12.65M

--15.68M

--20.88M

--23.39M

Current period cash flow changes

-103.68%-5.92M

-1488.37%-406.06M

-97.40%3.26M

17.10%-30.33M

44.31%160.61M

-32.38%29.25M

465.15%125.06M

-24.41%-36.58M

53.76%111.30M

9.17%43.25M

-243.87%-34.25M

-126.79%-29.40M

5071.22%72.38M

355.84%39.62M

263.60%23.80M

28.33%-12.96M

86.36%-1.46M

-93.42%8.69M

-33.78%-14.55M

-120.06%-18.09M

-122.47%-10.67M

2495.97%132.07M

-258.86%-10.88M

1834.35%90.17M

1990.09%47.50M

---5.51M

---3.03M

---5.20M

---2.51M

Ending cash balance

-60.81%282.95M

-48.54%288.86M

30.59%694.92M

69.91%691.66M

62.74%721.99M

68.91%561.38M

84.06%532.13M

25.89%407.07M

25.77%443.65M

18.54%332.36M

20.08%289.11M

49.05%323.35M

53.43%352.76M

21.18%280.38M

8.12%240.75M

-8.55%216.95M

-9.95%229.91M

-13.02%231.37M

66.27%222.68M

63.83%237.23M

367.33%255.32M

3627.97%265.99M

958.95%133.93M

823.60%144.80M

161.69%54.63M

--7.13M

--12.65M

--15.68M

--20.88M

Free cash flow

-102.24%-3.60M

40.76%-27.43M

110.09%3.12M

24.35%-30.34M

452.93%160.61M

-78.07%-46.30M

10.56%-30.89M

-28.80%-40.11M

-28.92%-45.51M

-19.30%-26.00M

-39.37%-34.53M

-34.49%-31.14M

-2142.50%-35.30M

-10.49%-21.79M

-69.88%-24.78M

-27.61%-23.16M

85.31%-1.57M

-144.99%-19.72M

-33.99%-14.59M

-82.29%-18.15M

-29.16%-10.71M

-45.96%-8.05M

-258.45%-10.89M

-91.33%-9.96M

-230.12%-8.30M

---5.52M

---3.04M

---5.20M

---2.51M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Keros Therapeutics Inc Generate?



Keros Therapeutics Inc generated 107.50M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Keros Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Keros Therapeutics Inc's operating cash flow increased by 166.83% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Keros Therapeutics Inc Spend on Capital Expenditures?



Keros Therapeutics Inc spent 1.55M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Keros Therapeutics Inc's Financing Cash Flow Changed?



Keros Therapeutics Inc used -378.47M in financing activities in the latest quarter.

What is free cash flow and why does it matter for KROS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Keros Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was 105.95M reflecting a 165.08% change from the previous year.